John Lally Selected Research

John Lally Research Topics

Disease

19	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 11/2013
11	Schizophrenia (Dementia Praecox) 02/2021 - 11/2011
10	Treatment-Resistant Schizophrenia 01/2022 - 04/2013
4	Neutropenia 01/2018 - 01/2017
4	Agranulocytosis (Granulocytopenia) 01/2018 - 01/2017
3	Weight Gain 04/2013 - 11/2011
2	Substance-Related Disorders (Drug Abuse) 06/2019 - 10/2013
2	Sinus Tachycardia 06/2016 - 06/2014
2	Tachycardia (Tachyarrhythmias) 06/2016 - 06/2014
1	Cerebral Cortical Thinning 01/2022
1	Gliosis 01/2021
1	Shock 01/2021
1	Hemorrhage 01/2021
1	Obesity 12/2019
1	Eosinophilia 09/2019
1	Neuroleptic Malignant Syndrome 07/2019
1	Tobacco Use Disorder (Nicotine Dependence) 06/2019
1	Syncope (Fainting) 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Hypertension (High Blood Pressure) 11/2018
1	Nephritis 10/2018
1	Hepatitis 10/2018
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2018
1	Pancreatitis 10/2018
1	Glioma (Gliomas) 01/2018
1	Hyperprolactinemia 11/2017
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2017
1	Constipation 06/2016
1	Multiple Sclerosis 01/2015
1	Vitamin D Deficiency 11/2013
1	Mental Disorders (Mental Disorder) 10/2013
1	Paranoid Schizophrenia (Delusional Disorder) 03/2013
1	Tardive Dyskinesia 03/2013
1	Dyskinesias (Dyskinesia) 03/2013
1	Mania (Manias) 06/2012
1	Giardiasis 06/2012
1	Mood Disorders (Mood Disorder) 06/2012
1	Body Weight (Weight, Body) 11/2011
1	Weight Loss (Weight Reduction) 11/2011
1	Xeroderma Pigmentosum (Kaposi's Disease) 09/2004
1	Ichthyosis (Xeroderma) 09/2004

Drug/Important Bio-Agent (IBA)

19	Clozapine (Clozaril)FDA LinkGeneric 01/2022 - 11/2011
11	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 11/2013
10	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 11/2011
6	Vitamin D FDA LinkGeneric 01/2022 - 11/2013
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2004
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 02/2015
3	AutoantibodiesIBA 01/2019 - 02/2015
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 10/2018
2	Acetylcysteine (Siran)FDA LinkGeneric 02/2020 - 10/2018
2	ProlactinIBA 08/2019 - 11/2017
2	AntibodiesIBA 01/2018 - 10/2017
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2018 - 10/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2017 - 08/2017
1	Calcium Channels (Calcium Channel)IBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2019
1	Nicotine FDA Link 06/2019
1	hydroxide ionIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 11/2018
1	imidazole mustard (BIC)IBA 01/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 10/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2017
1	CytokinesIBA 08/2017
1	N-Methylaspartate (NMDA)IBA 02/2015
1	IvabradineIBA 06/2014
1	LipidsIBA 04/2013
1	Paliperidone Palmitate FDA Link 03/2013
1	Olanzapine (Zyprexa)FDA Link 06/2012
1	Quinacrine (Mepacrine)IBA 06/2012
1	EndonucleasesIBA 09/2004

Therapy/Procedure

6	Therapeutics 12/2017 - 11/2011
2	Oral Administration 02/2020 - 10/2018
1	Compressed Air 01/2021
1	Length of Stay 01/2020
1	Polypharmacy 04/2013